Experience Sleepio,
Daylight, and Spark
Direct firsthand

Learn why so many organizations choose Big Health to support their population with insomnia, anxiety, and depression.

Sleepio is a customized six-week program that teaches techniques based on cognitive behavioral therapy (CBT) principles to treat insomnia, such as progressive relaxation, thought-blocking, sleep restriction, and mindful observation.

Daylight is a tailored four-week program that teaches CBT techniques to treat anxiety. Applied relaxation, cognitive restructuring, stimulus control, and imaginal exposure help patients respond better to stress and overcome worry and anxiety.

Spark Direct is a tailored five-week program for people 13+ with depression. Adolescents are guided through cognitive behavioral techniques to help them improve mood through interactive and engaging exercises.

Ready to help millions back to good mental health?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food & Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively. Users are directed to not make any changes to their prescribed medication or other type of medical treatment without seeking professional medical advice.

Spark Direct is a digital program that may help individuals live well with major depressive disorder (MDD) and symptoms of depression by providing them with cognitive and behavioral technique that can improve mood. Spark Direct has not been reviewed or approved by the Food & Drug Administration and is not intended to diagnose or treat any medical condition. Please read the instructions for use.

DOC-3159 Effective 11/2023